R&D Magazine February 2014 IDBS has introduced enhanced screening and analysis functionality in ActivityBase XE 7.7. The latest release addresses growing assay volumes for high-content and multiparametric data sets by processing information up to 50 times faster than the previous…
PharmaTimes February 2014 IDBS has been enlisted in a Canadian programme that aims to redefine cancer as a collection of rare diseases with specific molecular signatures, aiding stratification in drug development. Read the article here »About IDBSContact us More news…
We use cookies and other tracking technologies to ensure that we give you the best experience on our website, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties.
Find out more about the cookies we use here.
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences or managing your cart items. You can set your browser to block or alert you about these cookies, but some parts of the site may not work then.
These cookies allow the provision of enhance functionality and personalization, such as videos, live chats, and form pre-population. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies, then some or all of these functionalities may not function properly.
These cookies allow us to count visits and traffic sources, so we can measure and improve the performance of our site. They help us know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is anonymous. If you do not allow these cookies, we will not know when you have visited our site.